Pharmadrug Inc C.PHRX

Alternate Symbol(s): LMLLF

Medical Care Cannabis

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.

CSE:PHRX - Post by User

Pharmadrug Inc

<< Previous

Bullboard Posts

Next >>

Post by Shineway03on Feb 04, 2021 8:38am

56 Views

Post# 32468409

New Era in Psychedelic Medicine

Sponsored Post: You might be glancing also for the best treatment for resistant depression? This idea here is interesting!

This renewed interest in psychedelics might spark by a pair of seemingly unrelated events. What's important to understand is that a paradigm shift is starting to taking shape within the Western medical community

In effect, scientists might increasingly intrigue by the therapeutic potential of psychedelics as treatments for a whole range of mental health disorders. Pyschedelic medicine thus has the potential to be a gold mine for early capitalists. Check disclaimer on profile and landing page.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading